“四位一体”联合术前访视在早期胃癌患者中的应用效果分析  

Effect of "Four in One" combined with Preoperative Visit on Patients with Early Gastric Cancer

作　　者：韩琳[1] 陆卫红[1] 李娜[1] 刘婕[1] 陈飞娟[1] 翟焕莉 舒亚莉[1] 

机构地区：[1]陕西中医药大学附属医院,陕西西安712000

出　　处：《中医药导报》2017年第12期30-33,44,共5页Guiding Journal of Traditional Chinese Medicine and Pharmacy

基　　金：国家自然科学基金资助项目(81273949);咸阳科学技术计划立项项目(2014K04-07);项目名称:术前访视新模式的建立对访视效果影响的应用研究

摘　　要：目的:观察四位一体联合术前访视模式治疗早期胃癌的临床疗效及其安全性。方法:将60例早期胃癌患者按随机数字表法分为治疗组和对照组,对照组予常规治疗和护理,治疗组在常规护理的基础上加用四位一体联合术前访视。结果:(1)治疗组总有效率为93.3%,对照组为70.0%,两组差异有统计学意义(P<0.05)。(2)治疗后治疗组中医证侯评分、SAS评分、SDS评分、QLQ-C30评分均明显优于对照组(P<0.05)。(3)治疗后治疗组CEA、CA72-4、CA19-9含量均明显低于对照组(P<0.05)。结论:四位一体联合术前访视模式能明显缓解早期胃癌患者的临床症状,改善患者焦虑抑郁状态,降低对患者生存质量的影响及血清中CEA、CA72-4、CA19-9水平。Objective： To observe the clinical efficacy of ＂four in one＂ combined with preoperative visit on patients with early gastric cancer and its safety analysis. Methods： The 60 patients with early gastric cancer were divided into treatment group and control group by random number method, the control group received routine treatment and care, treatment group was treated with ＂four in one＂ combined with preoperative visit. Results： （1） The total effective rate of treatment group was 93.3%, and the control group was 70.0% （P〈O.05）. （2） After treatment, the treatment group of TCM symptom scores, SAS scores, SDS scores and QLQ-C30 scores were significantly better than the control group （P〈0.05）. （3）After treatment, the treatment group with CEA, CA72-4, CA19-9 scores were significantly lower than the control group （P〈0.05）. Conclusion： ＂four in one＂ combined with preoperative visit can significantly relieve symptoms in patients with early gastric cancer, improve patient anxiety and depression, reduce the impact on the quality of life of patients and reduce patient serum CEA, CA72-4, sugars associated antigen CA19-9.

关 键 词：胃癌 早期 四位一体 术前访视 临床护理 

分 类 号：R273[医药卫生—中西医结合]